First person – Santu Saha

Saha, S. 2023. First person – Santu Saha. Biology Open. 12 (5) bio059987. https://doi.org/10.1242/bio.059987

TitleFirst person – Santu Saha
TypeJournal article
AuthorsSaha, S.
Abstract

First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping researchers promote themselves alongside their papers. Santu Saha is first author on ‘ Bioengineering of a tumour-stroma 3D-tumouroid co-culture model of hypopharyngeal cancer’, published in BiO. Santu conducted the research described in this article while a Newton International Fellow of Academy of Medical Sciences (Research Associate) in Professor Nicola Curtin's lab at Newcastle University. He is now a Research Associate in the lab of Professor Christine Harrison at Leukaemia Research Cytogenetics Group at Newcastle University. He is a passionate early-career translational cancer researcher and my long-term research interest is in exploring gene – drug association based targeted cancer therapy through exploiting novel tools.

Article numberbio059987
JournalBiology Open
Journal citation12 (5)
ISSN2046-6390
Year2023
PublisherThe Company of Biologists
Publisher's version
License
CC BY 4.0
File Access Level
Open (open metadata and files)
Digital Object Identifier (DOI)https://doi.org/10.1242/bio.059987
Web address (URL)http://dx.doi.org/10.1242/bio.059987
Publication dates
Published25 May 2023

Related outputs

Bioengineering of a tumour-stroma 3D-tumouroid co-culture model of hypopharyngeal cancer.
Saha, S., Howarth, R., Sharma-Saha, S. and Kelly, C. 2023. Bioengineering of a tumour-stroma 3D-tumouroid co-culture model of hypopharyngeal cancer. Biology Open. 12 (5) bio059949. https://doi.org/10.1242/bio.059949

Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy.
Saha, S., Rundle S, Kotsopoulos IC, Begbie J, Howarth R, Pappworth IY, Mukhopadhyay A, Kucukmetin A, Marchbank KJ and Curtin N 2022. Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy. Cancers. 14 (17) 4288. https://doi.org/10.3390/cancers14174288

Survival outcomes of parotid carcinoma treated with surgery and radiotherapy or radiotherapy alone.
Iqbal, M.S., Jamil, F., Kovarik, J., Cunnell, M., Kelly, C. and Saha, S. 2022. Survival outcomes of parotid carcinoma treated with surgery and radiotherapy or radiotherapy alone. ICHNO–ECHNO 2022 Congress. Brussels, Belgium 03 - 05 Mar 2022

Molecular approaches toward targeted cancer therapy with some food plant products: On the role of antioxidants and immune microenvironment
Khuda-Bukhsh, A.R., Saha, S., Das, S. and Saha. S.S. 2021. Molecular approaches toward targeted cancer therapy with some food plant products: On the role of antioxidants and immune microenvironment. in: Preedy, V.R. and Patel, V.B. (ed.) Cancer (2nd edition) Academic Press. pp. 191-202

HCV Activates Somatic L1 Retrotransposition-A Potential Hepatocarcinogenesis Pathway.
Sudhindar, P.D., Wainwright, D., Saha, S., Howarth, R., McCain, M., Bury, Y., Saha, S.S., McPherson, S., Reeves, H., Patel, A.H., Faulkner, G.J., Lunec, J. and Shukla, R. 2021. HCV Activates Somatic L1 Retrotransposition-A Potential Hepatocarcinogenesis Pathway. Cancers. 13 (20) 5079. https://doi.org/10.3390/cancers13205079

PARP inhibitors: A new frontier in the battle against cervical cancer
Saha, S. 2021. PARP inhibitors: A new frontier in the battle against cervical cancer. SelectScience.

Introduction to Cancer Stem Cells
Saha, S., Khuda-Bukhsh, A.R., Samadder, A. and Saha, S.K. 2020. Introduction to Cancer Stem Cells. in: Pathak, S. and Banerjee, A. (ed.) Cancer Stem Cells: New Horizons in Cancer Therapies Springer.

Potential use of the PARP inhibitor rucaparib to enhance cervical cancer treatment
Saha, S., Howarth, R., Pappworth, I., Marchbank, K. and Curtin, N. 2020. Potential use of the PARP inhibitor rucaparib to enhance cervical cancer treatment. European Journal of Cancer. 138 (Supp 2), p. S37. https://doi.org/10.1016/s0959-8049(20)31169-2

SP-0517: Exploring rucaparib as chemo-radiosensitiser to increase therapeutic ratio in cervical cancer
Saha, S., Howarth, R., Dubrovska, A., Marchbank, K. and Curtin, N. 2020. SP-0517: Exploring rucaparib as chemo-radiosensitiser to increase therapeutic ratio in cervical cancer. Radiotherapy & Oncology. 152 (Supp 1), pp. S283-S284. https://doi.org/10.1016/S0167-8140(21)00539-9

Association of Hyaluronan and CD44 during development of Head and Neck Squamous Cell Carcinoma in Indian patients
Mukhopadhyay, D., Chakraborty, B., Alam, N., Biswas, J., Roy, A., Roychoudhury, S., Panda, C.K. and Saha, S. 2017. Association of Hyaluronan and CD44 during development of Head and Neck Squamous Cell Carcinoma in Indian patients. Recent Trends in Microbiology Conference. RK Mission, Kolkata, India

Molecular progression of Head and Neck Squamous Cell Carcinoma
Saha, S., Maiti, G.P., Roychoudhury, S. and Panda, C.K. 2017. Molecular progression of Head and Neck Squamous Cell Carcinoma. The Nucleus. 60, pp. 111-119. https://doi.org/10.1007/s13237-017-0212-9

Molecular Approaches Toward Targeted Cancer Therapy with Some Food Plant Products
Khuda-Bukhsh, A.R., Saha, S. and Das, S. 2014. Molecular Approaches Toward Targeted Cancer Therapy with Some Food Plant Products. in: Preedy, V. (ed.) Cancer Academic Press. pp. 77-89

Molecular approaches toward targeted cancer prevention with some food plants and their products: inflammatory and other signal pathways
Khuda-Bukhsh, A.R., Das, S. and Saha, S. 2014. Molecular approaches toward targeted cancer prevention with some food plants and their products: inflammatory and other signal pathways. Nutrition and Cancer. 66 (2), pp. 194-205. https://doi.org/10.1080/01635581.2014.864420

Berberine alters epigenetic modifications, disrupts microtubule network, and modulates HPV-18 E6--E7 oncoproteins by targeting p53 in cervical cancer cell HeLa: A mechanistic study including molecular docking
Saha, S. and Khuda-Bukhsh, A.R. 2014. Berberine alters epigenetic modifications, disrupts microtubule network, and modulates HPV-18 E6--E7 oncoproteins by targeting p53 in cervical cancer cell HeLa: A mechanistic study including molecular docking. European Journal of Pharmacology. 744, pp. 132-146. https://doi.org/10.1016/j.ejphar.2014.09.048

Water-Soluble Heteronuclear [NaCuII6] Metallomacrocyclic Sandwich Complexes: Synthesis, Structure, Properties and In Vitro Biological Studies
Patra, A., Saha, S., Sen, T.K., Carrella, L., Musie, G.T., Khuda-Bukhsh, A.R. and Bera, M. 2014. Water-Soluble Heteronuclear [NaCuII6] Metallomacrocyclic Sandwich Complexes: Synthesis, Structure, Properties and In Vitro Biological Studies. European Journal of Inorganic Chemistry. Volume 2014 (30), pp. 5217-5232. https://doi.org/10.1002/ejic.201402582

Poly (lactic-co-glycolic) acid loaded nano-insulin has greater potentials of combating arsenic induced hyperglycemia in mice: some novel findings
Asmita Samadder, A., Das, J., Das, S., De, A., Saha, S., Bhattacharyya, S.S. and Khuda-Bukhsh, A.R. 2013. Poly (lactic-co-glycolic) acid loaded nano-insulin has greater potentials of combating arsenic induced hyperglycemia in mice: some novel findings. Toxicology and Applied Pharmacology. 267 (1), pp. 57-73. https://doi.org/10.1016/j.taap.2012.12.018

Ethanolic extract of the Goldenseal, Hydrastis canadensis, has demonstrable chemopreventive effects on HeLa cells in vitro: Drug--DNA interaction with calf thymus DNA as target
Saha, S., Sikdar, S., Mukherjee, A., Bhadra, K., Boujedaini, N. and Khuda-Bukhsh, A.R. 2013. Ethanolic extract of the Goldenseal, Hydrastis canadensis, has demonstrable chemopreventive effects on HeLa cells in vitro: Drug--DNA interaction with calf thymus DNA as target. Environmental Toxicology and Pharmacology. 36 (1), pp. 202-214. https://doi.org/10.1016/j.etap.2013.03.023

Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends
Saha, S. and Khuda-Bukhsh, A.R. 2009. Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends. European Journal of Pharmacology. 714 (1-3), pp. 239-248. https://doi.org/10.1016/j.ejphar.2013.06.009

Permalink - https://westminsterresearch.westminster.ac.uk/item/x5269/first-person-santu-saha


Share this

Usage statistics

19 total views
13 total downloads
These values cover views and downloads from WestminsterResearch and are for the period from September 2nd 2018, when this repository was created.